{"url_path":"/sec/celz/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-004165-index.html","accession_number":"0001477932-26-004165","cik":"0001187953","ticker":"CELZ","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-004165-index.html","primary_entity_key":"0001187953","primary_entity_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n[4.1](celz_ex41.htm)\n[Form of Inducement Warrant](celz_ex41.htm)\n\n[10.1](celz_ex101.htm)\n[Form of Inducement Letter](celz_ex101.htm)\n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**Creative Medical Technology Holdings, Inc.**\n\n \n\n \n\n \n\n \n\nDate: July 2, 2026\n\nBy:\n\n*/s/ Timothy Warbington*\n\n \n\n \n\n \n\nTimothy Warbington, Chief Executive Officer\n\n \n\n \n\n \n\n3"}